Doxazosin Tablet
Product Images NDC 68071-4272

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68071-4272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4272 3

This appears to be a description of a pharmaceutical product, specifically a bottle of Doxazosin tablets. The product label includes information such as the manufacturer, lot number, expiration date, and unique serial number as well as instructions to keep the medication out of reach of children and to contact a doctor for any side effects. There is also a warning to store the medication at a controlled temperature between 59-86°F.*

FDA Label Image

Table 1 (Doxazosin Fig1)

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

This is a table that displays the mean increase in maximum urinary flow rate (mUsec) and the mean change in total symptom score from baseline. The table also includes a placebo group showing no significant change. The duration of treatment is indicated in weeks. The note at the bottom indicates statistical significance when compared to the placebo group and baseline. Doxazosin was titrated up to a maximum of 8 mg.*

FDA Label Image

Chemical Structure (Doxazosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.